執(zhí)照.jpg)
丹參素
分析標準品,HPLC≥98%
Danshensu
CAS號：76822-21-4
分子式：C9H10O5
分子量：198.17
MDL：MFCD07781415
貨號 | 規(guī)格/參數(shù)/品牌 | 價格 | 貨期 |
YJ-B20254-20mg | 分析標準品,HPLC≥98% | ￥500.00 | 現(xiàn)貨 |
YJ-B20254-200mg | 分析標準品,HPLC≥98% | ￥2860.00 | 現(xiàn)貨 |
JS31458-1g | ≥98% | ￥1300.00 | 現(xiàn)貨 |
JS31458-10g | ≥98% | ￥4600.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點：84-86℃
沸點：481.5 ℃ at 760 mmHg
比旋光度：+11.5°(甲醇)
外觀：白色長針狀結(jié)晶
溶解性：可溶于水及常見的有機溶劑中，如甲醇、乙醇、丙tong、乙mi等。
儲存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(46篇)
46. [IF=3.4] Wang Qiaona et al."Anti-oxidative effect of Salvia miltiorrhiza Bunge fermented with Shiraia bambusicola Henn. against H2O2-induced injury in PC12 cells."BMC Complementary Medicine and Therapies.2025 Dec;25(1):1-13
45. [IF=4] Lijuan Wu et al."Integration of chromatographic fractionation, quantitative 1H-NMR and serially coupled achiral-chiral LC–MS/MS enables multi-components-targeted determination of Salvia miltiorrhiza in an authentic compound-independent manner."JOURNAL OF
44. [IF=4.9] Kewei Zuo et al."Transcriptome- and Metabolome-Based Regulation of Growth, Development, and Bioactive Compounds in Salvia miltiorrhiza (Lamiaceae) Seedlings by Different Phosphorus Levels."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2025 Jan;26(13):6253
43. [IF=3.8] Liping Zhang et al."Comprehensive characterization of active components in Salvia miltiorrhiza using polarity-partitioned two-dimensional liquid chromatography coupled with mass spectrometry."JOURNAL OF CHROMATOGRAPHY A.2024 Oct;:465424
42. [IF=1.5] Huijuan Tao et al."Danshensu and Notoginsenoside R1 Combination Alleviates Obesity in Mice Via Modification of Gut Microbiota and Short-Chain Fatty Acids."Natural Product Communications.;():
41. [IF=5.7] Yue Wang et al."Precise Molecularly Imprinted Montmorillonite for Selective Adsorption of Salvianolic Acid A with Ultra-large Capacity."Surfaces and Interfaces.2025 Jan;:105741
40. [IF=5.3] Yao Chen et al."Biomimetic metal-phenolic nanocarrier for co-delivery of multiple phytomedical bioactive components for anti-atherosclerotic therapy."INTERNATIONAL JOURNAL OF PHARMACEUTICS.2025 Jan;:125228
39. [IF=4.8] Chuang Li et al."Integrative analyzing the molecular basis of Clerodendranthus Spicatus aqueous extract in hyperuricemia nephropathy via network pharmacology and experimental validation."Food Bioscience.2025 Feb;:106152
38. [IF=4.7] Yule Wang et al."Guanxinning Tablet Alleviates Post-Ischemic Stroke Injury Via Regulating Complement and Coagulation Cascades Pathway and Inflammatory Network Mobilization."Drug Design Development and Therapy.
37. [IF=4.8] Qingquan Li et al."Identification of Senkyunolide I as a novel modulator of hepatic steatosis and PPARα signaling in zebrafish and hamster models."JOURNAL OF ETHNOPHARMACOLOGY.2025 Jan;336:118743
36. [IF=4.8] Ze-Yu Zhang et al."Mechanism of action of the Banxia–Xiakucao herb pair in sleep deprivation: New comprehensive evidence from network pharmacology, transcriptomics and molecular biology experiments."JOURNAL OF ETHNOPHARMACOLOGY.2024 Nov;334:118534
35. [IF=1.1] Ji-Yong FU et al."Simultaneous determination of 19 constituents in the Jian-Nao-Ning mixture using high-performance liquid chromatography-tandem mass spectrometry."Separation Science Plus".2024 Feb;:2300222
34. [IF=5.4] Yingqiu Shi et al."Effective constituents and protective effect of Mudan granules against Schwann cell injury."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117692
33. [IF=3.4] Jia Sun et al."Analysis of compatibility mechanism of shenxiong glucose injection after multiple dosing based on differences of PK-PD correlation and cytochrome P450 enzyme."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Feb;239:115899
32. [IF=4.9] Qingfa Tang et al."ROS-Responsive Prodrug Micelle Co-Delivery System for Synergistic Antiatherosclerotic Therapy."MOLECULAR PHARMACEUTICS.2023;XXXX(XXX):XXX-XXX
31. [IF=3.318] Jun-Ming Li et al."A sensitive LC-MS/MS method-based pharmacokinetic study of fifteen active ingredients of Yindan Xinnaotong soft capsule in rats and its potential mechanism in the treatment of cardiovascular diseases."JOURNAL OF CHROMATOGRAPHY B-ANALYTI
30. [IF=6.449] Chaogeng Lyu et al."A field trials-based study reveals the effects of chlormequat chloride on the quality of medicinal plant Salvia miltiorrhiza Bge. (Lamiaceae) in practical cultivation."INDUSTRIAL CROPS AND PRODUCTS.2023 Apr;194:116396
29. [IF=4.927] Jinyang Fang et al."Discovery of Natural Small Molecules Promoting Collagen Secretion by High-Throughput Screening in Caenorhabditis elegans."MOLECULES.2022 Jan;27(23):8361
28. [IF=4.927] Ke Shun Hu et al."Production of Salvianic Acid A from l-DOPA via Biocatalytic Cascade Reactions."MOLECULES.2022 Jan;27(18):6088
27. [IF=2.464] Zhou Huifen et al."Pharmacokinetic-Pharmacodynamic Modeling of Active Components from Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) in Focal Cerebral Ischemia Rats."Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy.
26. [IF=6.627] Jiadong Hu et al."Identification of Abietane-Type Diterpenoids and Phenolic Acids Biosynthesis Genes in Salvia apiana Jepson Through Full-Length Transcriptomic and Metabolomic Profiling."Frontiers in Plant Science.2022; 13: 919025
25. [IF=9.078] Jun Qian et al."A strategy for effective recovery of salvianolic acid a from Salvia miltiorrhiza (Danshen) through multiple interactions."Compos Part B-Eng. 2022 Feb;231:109563
24. [IF=6.057] Qi Tong et al.Biosynthesis-based spatial metabolome of Salvia miltiorrhiza Bunge by combining metabolomics approaches with mass spectrometry-imaging.Talanta. 2021 Nov;:123045
23. [IF=3.512] Yahong Chen et al."Identification of Potential Human Ryanodine Receptor 1 Agonists and Molecular Mechanisms of Natural Small-Molecule Phenols as Anxiolytics."Acs Omega. 2021;XXXX(XXX):XXX-XXX
22. [IF=4.36] Jing Chen et al."Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling."J Ethnopharmacol. 2021 Sep;:114667
21. [IF=4.759] Yi Zhang et al."Screening of inhibitors against histone demethylation jumonji domain-containing protein 3 by capillary electrophoresis."J Chromatogr A. 2020 Feb;1613:460625
20. [IF=5.81] Jun Li et al."Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish."Front Pharmacol. 2020; 11: 622787
19. [IF=5.81] Chenning Zhang et al."Global Analysis the Potential Medicinal Substances of Shuangxia Decoction and the Process In Vivo via Mass Spectrometry Technology."Front Pharmacol. 2021; 12: 654807
18. [IF=6.475] Shi Qiu et al."Selection of appropriate post-harvest processing methods based on the metabolomics analysis of Salvia miltiorrhiza Bunge."Food Res Int. 2021 Jun;144:110366
17. [IF=3.049] Jixia Wang et al."Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay."Rsc Adv. 2015 Mar;5(33):25768-25776
16. Wang, Jixia, et al. "Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay." RSC Advances 5.33 (2015): 25768-25776.https:##doi.org/10.1039/C4RA16102E
15. Li J, Liu H, Yang Z, Yu Q, Zhao L, Wang Y. Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish. Front Pharmacol. 2021;11:622787. Published 2021 Jan 14. doi:10.3389/fphar.2020.6
14. Cheng, Yan, et al. "Decomposition of five phenolic compounds in high temperature water." Journal of the Brazilian Chemical Society 25 (2014): 2102-2107.https:##doi.org/10.5935/0103-5053.20140201
13. 黑小斌,李歡,李慧,梁小燕,高靜,彭亮,李依民,張崗.丹參無菌培養(yǎng)體系構(gòu)建及有效成分含量的HPLC分析[J].中草藥,2020,51(22):5833-5838.
12. 李清清 張繼芬. 冠心寧中14種成分的含量測定[J]. 蘇鹽科技 2019 046(006):33-35.
11. 支旭然 劉洪濤 吳茵 等. UPLC-MS/MS法同時測定腎康注射液中7個有效成分[J]. 藥物分析雜志 2017 037(001):37-42.
10. 黃娟, 丘小惠, 白俊其,等. 根莖類藥材丹參精準煮散飲片的質(zhì)量評價[J]. 中國實驗方劑學雜志, 2017, 023(011):18-22.
9. 支旭然 董占軍 吳茵 等. HPLC同時測定腎康注射液中的4種成分[J]. 華西藥學雜志 2017(03):297-299.
8. 崔偉亮 李慧芬 張學蘭 等. UPLC-QE/MS法分析丹參酒炙前后5種質(zhì)變化合物[J]. 中成藥 2019 041(004):844-849.
7. 周惠芬 何昱 艾進超 等. 丹紅注射液主要有效成分配伍在腦缺血再灌注大鼠體內(nèi)的藥動學研究[J]. 中草藥 2016(20).
6. 梁琨 孫輝 安叡 等. LC-MS/MS法同時測定護心口服液中11種成分[J]. 中成藥 2018 040(001):105-109.
5. 唐一梅, 高蘇亞, 張彥,等. 離子液體輔助提取丹參中丹參素的工藝條件及機理[J]. 化工科技, 2018, 026(003):42-46.
4. 王紅玉, 李晶晶, 周瑩,等. 欣夢顆粒中丹參素在大鼠體內(nèi)的藥動學研究[J]. 中藥新藥與臨床藥理, 2017(4).
3. 陳錢 林慧 于敬偉 等. 丹參素在體外條件下對口腔鱗癌細胞CAL-27抑制作用的研究[J]. 口腔醫(yī)學 2019 039(002):113-116.
2. 葉鳳 曹文富.丹參含藥血清調(diào)節(jié)大鼠肝星狀細胞TGF-β1及細胞周期素CyclinD1的機制研究[J].重慶醫(yī)科大學學報 2016 41(04):369-373.
1. 范紅晶 劉晨敏 楊潔紅 等. 丹參中丹參素的提取工藝優(yōu)化研究[J]. 中華中醫(yī)藥學刊 2016 v.34(04):782-784.
從2011年開始我們致力于在生命科學領(lǐng)域、生物醫(yī)學實驗技術(shù)及論文潤色服務(wù)，協(xié)助客戶各類實驗服務(wù)及論文潤色十余年，是客戶您值得信賴的科研合作伙伴!
如果您受時間、試驗條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實驗技術(shù)服務(wù)：
